[1] 高颖龙,温颖,何洪涛,等. 2009~2014年广东口岸肺结核患者耐药情况监测分析[J].中国国境卫生检疫杂志,2016,39(1):5-8.
[2] Yang JS, Kim KJ, Choi H,et al. Delamanid, bedaquiline, and linezolid minimum inhibitory concentration distributions and resistance-related gene mutations in multidrug-resistant and extensively drug-resistant tuberculosis in Korea[J].Ann Lab Med,2018,38(6):563-564.
[3] Thida Oo NA, San LL, Thapa J, et al. Characterization of mutations conferring streptomycin resistance to multidrug-resistant Mycobacterium tuberculosis isolates from Myanmar[J].Tuberculosis,2018,111(8):8-13.
[4] 余旭良,金菊仙,陆军,等. 134例耐多药肺结核耐药情况分析[J].中国卫生检验杂志,2018,28(9):1114-1116.
[5] 赵承杰,何雪姣,胡跃强. 293例新发涂阳肺结核病人治愈率影响因素及耐药情况分析[J].中国农村卫生事业管理,2017,37(10):1215-1217.
[6] 任易, 彭孝红, 徐晶,等. 肺结核和肺外结核患者外周血淋巴细胞亚群及血液相关指标的变化比较[J].医学临床研究, 2017, 34(1):173-175.
[7] 梁汉成,魏萍,黄宁. 300例涂阳肺结核临床表型与耐药情况分析[J].广东医科大学学报,2017,35(4):421-423.
[8] 王瑞,殷雨天,张鹏,等. 395例痰结核菌培养阳性肺结核患者耐药情况分析[J].中国实验诊断学,2015,19(8):1343-1346.
[9] Duan H.Clofazimine improves clinical outcomes in multidrug-resistant tuberculosis: a randomized controlled trial[J].Clin Microbiol Infect,2018,34(6):90-93.
[10] Alene KA, Clements ACA, Mcbryde ES, et al. Mental health disorders, social stressors, and health-related quality of life in patients with multidrug-resistant tuberculosis: A systematic review and meta-analysis[J].J Infect,2018,32(6):103-105.
[11] Walker IF, Khanal S, Hicks JP, et al. Implementation of a psychosocial support package for people receiving treatment for multidrug-resistant tuberculosis in Nepal: A feasibility and acceptability study[J].PLoS One,2018,13(7):163-165.
[12] 刘群群,苗艳芳. 651例住院肺结核患者结核分枝杆菌耐药情况分析[J].中国防痨杂志,2015,37(4):406-408.
[13] 辛云巧,李春菊,李立军,等. 北京市丰台区67例耐多药肺结核患者的回顾性分析[J].中国防痨杂志,2015,37(4):400-403.
[14] 顾连英,周冀. 馆陶县2012至2014年初治涂阳肺结核患者分枝杆菌培养及耐药[J].中华实验和临床感染病杂志(电子版),2016,10(4):485-488.
2018, Vol. 35 
